Home › NDC Lookup › RxCUI directory › RxCUI 1488574

Dapagliflozin 5 MG Oral Tablet — RxCUI 1488574

RxNorm drug concept · Semantic clinical drug
RxCUI 1488574 Semantic clinical drug · SCD ● Current RxNorm concept 42 FDA products 89 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1488574
Official nameDapagliflozin 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped42
Package NDCs mapped89
Reported Medicaid activity (SDUD)1,339,664 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dapagliflozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, it's used for more than just blood sugar control. Dapagliflozin is approved to help manage type 2 diabetes, but it's also used to reduce the risk of serious heart failure compl...
  • What is dapagliflozin actually used for — is it just for diabetes?
  • You can take it either way — with or without food. A high-fat meal may slow how quickly it absorbs slightly, but it doesn't change the overall amount that gets into your system. Ju...
  • Can I take this tablet with food, or does it have to be on an empty stomach?
📖 Read our full Dapagliflozin guide →

🕸️ Concept Web — How Dapagliflozin 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dapagliflozin 5 MG Oral Tablet RxCUI 1488574

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dapagliflozin 1488564
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Farxiga 1486972
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dapagliflozin Oral Tablet 1488568
    • Dapagliflozin Oral Product 1488566
    • Dapagliflozin Pill 1488567
    • Dapagliflozin Oral Tablet [Farxiga] 1534343
    • Farxiga Oral Product 1486975
    • Farxiga Pill 1486976
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dapagliflozin 5 MG SCDC · 1488573
  • Dapagliflozin Oral Tablet SCDF · 1488568
  • Dapagliflozin Oral Product SCDG · 1488566
  • Dapagliflozin Pill SCDG · 1488567

Brand-Name Concepts

  • Dapagliflozin 5 MG Oral Tablet [Farxiga] SBD · 1486981
  • Dapagliflozin 5 MG [Farxiga] SBDC · 1534344
  • Dapagliflozin Oral Tablet [Farxiga] SBDF · 1534343
  • Farxiga Oral Product SBDG · 1486975
  • Farxiga Pill SBDG · 1486976
  • Farxiga BN · 1486972

📦 FDA Products & Package NDCs

42 products · 89 package NDCs
89 package NDCs map to RxCUI 1488574 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00310-6205-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6205-30) FARXIGA AstraZeneca Pharmaceuticals LP 2015-02-02
00310-6205-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6205-90) FARXIGA AstraZeneca Pharmaceuticals LP 2024-03-18
00310-6205-95 1 BLISTER PACK in 1 CARTON (0310-6205-95) / 7 TABLET, FILM... FARXIGA AstraZeneca Pharmaceuticals LP 2015-02-02
00310-6210-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6210-30) FARXIGA AstraZeneca Pharmaceuticals LP 2015-01-05
00310-6210-39 3 BLISTER PACK in 1 CARTON (0310-6210-39) / 10 TABLET, FILM... FARXIGA AstraZeneca Pharmaceuticals LP 2022-12-02
00310-6210-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-6210-90) FARXIGA AstraZeneca Pharmaceuticals LP 2024-03-18
00310-6210-95 1 BLISTER PACK in 1 CARTON (0310-6210-95) / 7 TABLET, FILM... FARXIGA AstraZeneca Pharmaceuticals LP 2015-01-05
00480-3527-05 500 TABLET, FILM COATED in 1 BOTTLE (0480-3527-05) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-06-04
00480-3527-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-3527-56) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-04-08
00480-3527-98 90 TABLET, FILM COATED in 1 BOTTLE (0480-3527-98) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-04-27
00480-3528-05 500 TABLET, FILM COATED in 1 BOTTLE (0480-3528-05) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-05-14
00480-3528-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-3528-56) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-04-08
00480-3528-98 90 TABLET, FILM COATED in 1 BOTTLE (0480-3528-98) DAPAGLIFLOZIN Teva Pharmaceuticals, Inc. 2026-04-27
00781-5985-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5985-01) Dapagliflozin Sandoz Inc 2026-04-06
00781-5985-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5985-05) Dapagliflozin Sandoz Inc 2026-04-06
00781-5985-10 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5985-10) Dapagliflozin Sandoz Inc 2026-04-06
00781-5985-31 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5985-31) Dapagliflozin Sandoz Inc 2026-04-06
00781-5990-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5990-01) Dapagliflozin Sandoz Inc 2026-04-06
00781-5990-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5990-05) Dapagliflozin Sandoz Inc 2026-04-06
00781-5990-10 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5990-10) Dapagliflozin Sandoz Inc 2026-04-06
00781-5990-31 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0781-5990-31) Dapagliflozin Sandoz Inc 2026-04-06
27241-0151-01 30 TABLET in 1 BOTTLE (27241-151-01) Dapagliflozin Ajanta Pharma USA Inc. 2026-04-06
27241-0152-01 30 TABLET in 1 BOTTLE (27241-152-01) Dapagliflozin Ajanta Pharma USA Inc. 2026-04-06
46708-0392-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-392-30) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-06
46708-0392-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-392-90) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-20
46708-0392-91 1000 TABLET, FILM COATED in 1 BOTTLE (46708-392-91) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-06
46708-0393-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-393-30) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-06
46708-0393-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-393-90) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-20
46708-0393-91 1000 TABLET, FILM COATED in 1 BOTTLE (46708-393-91) DAPAGLIFLOZIN Alembic Pharmaceuticals Limited 2026-04-06
50090-7056-00 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7056-0) DAPAGLIFLOZIN A-S Medication Solutions 2024-01-16
50090-7971-00 30 TABLET, FILM COATED in 1 BOTTLE (50090-7971-0) Dapagliflozin A-S Medication Solutions 2026-05-14
55154-6933-08 840 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6933-8) FARXIGA Cardinal Health 107, LLC 2015-01-05
59651-0159-30 30 TABLET, FILM COATED in 1 BOTTLE (59651-159-30) Dapagliflozin Aurobindo Pharma Limited 2026-04-06
59651-0159-90 90 TABLET, FILM COATED in 1 BOTTLE (59651-159-90) Dapagliflozin Aurobindo Pharma Limited 2026-05-08
59651-0160-30 30 TABLET, FILM COATED in 1 BOTTLE (59651-160-30) Dapagliflozin Aurobindo Pharma Limited 2026-04-06
59651-0160-90 90 TABLET, FILM COATED in 1 BOTTLE (59651-160-90) Dapagliflozin Aurobindo Pharma Limited 2026-05-08
60505-4911-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-4911-3) Dapagliflozin Apotex Corp. 2026-04-08
60505-4912-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-4912-3) Dapagliflozin Apotex Corp. 2026-04-08
62332-0392-30 30 TABLET, FILM COATED in 1 BOTTLE (62332-392-30) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-06
62332-0392-90 90 TABLET, FILM COATED in 1 BOTTLE (62332-392-90) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-20
62332-0392-91 1000 TABLET, FILM COATED in 1 BOTTLE (62332-392-91) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-06
62332-0393-30 30 TABLET, FILM COATED in 1 BOTTLE (62332-393-30) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-06
62332-0393-90 90 TABLET, FILM COATED in 1 BOTTLE (62332-393-90) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-20
62332-0393-91 1000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91) DAPAGLIFLOZIN Alembic Pharmaceuticals Inc. 2026-04-06
66993-0456-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-456-30) DAPAGLIFLOZIN Prasco Laboratories 2024-01-03
66993-0457-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30) DAPAGLIFLOZIN Prasco Laboratories 2024-01-03
67877-0608-05 500 TABLET, FILM COATED in 1 BOTTLE (67877-608-05) Dapagliflozin Ascend Laboratories, LLC 2026-04-06
67877-0608-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-608-30) Dapagliflozin Ascend Laboratories, LLC 2026-04-06
67877-0608-33 1 BLISTER PACK in 1 CARTON (67877-608-33) / 10 TABLET, FILM... Dapagliflozin Ascend Laboratories, LLC 2026-04-06
67877-0608-90 90 TABLET, FILM COATED in 1 BOTTLE (67877-608-90) Dapagliflozin Ascend Laboratories, LLC 2026-04-06
Observed labelers: Ascend Laboratories, LLC (8) · Sandoz Inc (8) · AstraZeneca Pharmaceuticals LP (7) · Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) · Florida Pharmaceutical Products, LLC (6) · +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.